Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

21.64
USD
+0.05
(+0.23%)
0.08EPS
222.50P/E
58.54BMarket Cap
Jan 28Next Earn

Takeda Pharmaceutical Co. Ltd. Documents

Q4 FY2025 · Presentation

Investor Call on Phase 3 PV Data Presented at ASCO 2025 · 49 pages

Read Takeda Pharmaceutical Co. Ltd.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q4 FY2025 documents